Accelerating BioVenture Innovation (ABI) is a 12-week course and training program in biomedical entrepreneurship. ABI builds teams around patented technologies originating from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Rockefeller University.

The first ABI class is scheduled for Tuesday, August 23. The Kick-Off event celebrates the entrepreneurial journey to be undertaken by participants. Join us to hear from our keynote speaker, Gene Marcantonio MD, PhD (biography below). You will also meet fellow participants and have the opportunity to network with entrepreneurs, peers from neighboring institutions, industry experts, and investors from the NYC ecosystem.

Agenda:

5:30 pm - Uris Auditorium (1300 York Ave)

Keynote Speaker:

Gene Marcantonio MD, PhD, CEO of ARMGO Pharma, Inc.

Dr. Marcantonio is currently CEO of ARMGO Pharma, Inc, a small biotech specializing in compounds that normalize leaky RyR channels. Prior to joining ARMGO he was Associate Vice President in Translational Pharmacology at Merck and Company where he led the efforts in early stage development for Infectious Diseases, Vaccines and Immunology. Previously, Dr. Marcantonio was a tenured faculty member of the College of Physicians & Surgeons of Columbia University in the Department of Pathology and Cell Biology where he led an active research effort on integrin receptor signaling and function. He was also an attending physician at New York Presbyterian Hospital and the director of the autopsy service. He received his pathology training at the Brigham & Women’s Hospital of Harvard Medical School and postdoctoral training at MIT. He received his MD PhD from NYU School of Medicine.

7:00 pm - Griffis Faculty Club (1300 York Ave)

Reception & Networking